Mina Foroughi

Mina Foroughi

Auto-generated profile, based on publicly available information

Mina Foroughi

Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
ASArman Sourani
Arman Sourani
NVNoushin Vahdat
Noushin Vahdat
CSColin Son
Colin Son
OHOmid R Hariri
Omid R Hariri
MRMajid Rezvani
Majid Rezvani
SMSadegh Baradaran Mahdavi
Sadegh Baradaran Mahdavi

1 January 2023 in Korean Journal of Neurotrauma
Verified
Journal Article
Open access
PDF file
MRMajid Rezvani
Majid Rezvani
JAJamalodin Asadi
Jamalodin Asadi
ASArman Sourani
Arman Sourani
MFMina Foroughi
Mina Foroughi
DTDonya Sheibani Tehrani
Donya Sheibani Tehrani
Rezvani M, et al. Korean J Neurotrauma. 2023 Mar;19:e9. https://doi.org/10.13004/kjnt.2023.19.e9

1 November 2022 in Stroke: Vascular and Interventional Neurology
Verified
Journal Article
Open access
PDF file
MSMasih Sabouri
Masih Sabouri
BABahram Aminmansour
Bahram Aminmansour
ASArman Sourani
Arman Sourani
MSMohammad Sharafi
Mohammad Sharafi
ASAhmad Sahraei
Ahmad Sahraei
MFMina Foroughi
Mina Foroughi
Background: To systematically summarize and critically review the available literature regarding the functional outcome of the urgent superficial temporal artery to the middle cerebral artery (MCA) bypass surgery in stroke patients associated with MCA lesions. Methods: The current systematic review was conducted and reported using the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis statement. Medline (PubMed), ISI Web of Science, Scopus, and google scholar (manually searches) were systematically searched up to August 2021. The eligibility criteria were defined as all the patients who had MCA‐territory strokes due to MCA/intradural internal carotid artery lesions that underwent same‐admission superficial temporal artery‐MCA bypass surgery. The strokes with cervical internal carotid artery and anterior cerebral artery lesions/strokes were excluded. The checklists produced by the US National Heart Lung and Blood Institute were used for quality assessment. Demographic variables, clinical findings, National Institutes of Health Stroke Scale scores, the time interval between symptoms to surgery, imaging results, endovascular treatments, surgical notes, mortality rate, follow‐up findings, modified Rankin scale scores, and all reported medical records were extracted and analyzed with SPSS software (ver. 23). P values ≤0.05 were considered meaningful. Results: The initial search yielded 3050 records, and 13 articles met the inclusion criteria and entered this systematic review. A total of 165 patients were pooled for data analysis. Nine studies had data regarding neurological deficits before and after surgery. Except for 5 patients, the National Institutes of Health Stroke Scale score after the operation was the same or better than the preoperative score. Eleven out of 17 patients in 3 studies showed early neurological improvement (a decrease in National Institutes of Health Stroke Scale score of ≥4 points at 3 days) after bypass surgery. Functional outcome was stated in 10 studies. Overall, a good functional outcome (modified Rankin scale=0–2) was achieved in 9 out of 21 (42.1%) patients at discharge and in 44 out of 59 (74.5%) patients at 3 months follow‐up. Lower age was associated with favorable outcomes. Long‐term graft patency was excellent in 99.5% of patients. Postoperative hematoma and mortality (all noncranial) rates were 3% and 3.6%, respectively. Conclusion: The current study suggests that early superficial temporal artery‐MCA revascularization should be considered an available option in younger patients (<60‐year‐old) with MCA territory strokes who fail medical treatment.

19 December 2022 in Clinical Case Reports
Verified
Journal Article
Open access
ASArman Sourani
Arman Sourani
MRMajid Rezvani
Majid Rezvani
MFMina Foroughi
Mina Foroughi
SMSadegh Baradaran Mahdavi
Sadegh Baradaran Mahdavi
A 67‐year‐old female was hospitalized due to right‐sided hemiparesis and neck pain with rapid deterioration to a deep coma. She had received the Sinopharm vaccine 2 days earlier. MRI showed extensive cervicothoracic hematomyelia. She received intensive medical care for 2 months and was discharged. An 18‐month follow‐up showed significant neurological recovery.

15 February 2024 in The Spine Journal
Verified
Journal Article
Closed access
ASArman Sourani
Arman Sourani
NVNoushin Vahdat
Noushin Vahdat
CBChristian A Bowers
Christian A Bowers
MRMajid Rezvani
Majid Rezvani
MFMina Foroughi
Mina Foroughi
SMSadegh Baradaran Mahdavi
Sadegh Baradaran Mahdavi

8 December 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MRMajid Rezvani
Majid Rezvani
MSMasih Sabouri
Masih Sabouri
BABahram Aminmansour
Bahram Aminmansour
SFSoheil Falahpour
Soheil Falahpour
ASArman Sourani
Arman Sourani
SVShaahin Veisi
Shaahin Veisi
Introduction: COVID-19 vaccination side effects are rare but important medical situations. Spine-affecting side effects are amongst the rarest, but exceedingly important. Haemorrhagic spinal manifestations of COVID-19 and its vaccines are less reported with little knowledge about them. Case presentation: An 80-year-old male who received his first shot of the COVID-19 vaccine had developed COVID-19 pneumonia, weakness, and sensory problems in his legs followed by sphincter incontinence within 5 days period. MRI showed a spontaneous epidural spinal epidural haematoma (SSEDH) in T10–L1. He underwent laminectomy and haematoma evacuation. One month follow-up showed no clinical improvement. Discussion: To our knowledge, this was the first post-vaccination SSEDH and second in haemorrhagic spinal complications following COVID-19 vaccination. Considering the neuropathogenesis pathway of COVID-19 and its vaccines, there are common mechanisms of action that could potentially justify post-vaccination SSEDH such as seen in COVID-19 infection, itself. Early Neurosurgical intervention and better preoperative neurological status could be a beneficial modifier for favourable clinical outcomes. Conclusion: SSEDH and COVID-19 vaccine coincidence is a rare clinical event, still no solid association could be scientifically explained. Further studies are required for a reliable pathophysiologic association. Early diagnosis, interdisciplinary medical approach, and faster intervention are the cornerstone of the treatment paradigm.